Cetera Investment Advisers’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.4K Hold
10,217
﹤0.01% 4822
2026
Q1
$20K Sell
10,217
-2
-0% -$5 ﹤0.01% 4658
2025
Q4
$27.7K Sell
10,219
-298
-3% -$978 ﹤0.01% 4559
2025
Q3
$44.5K Buy
10,517
+433
+4% +$1.9K ﹤0.01% 4438
2025
Q2
$50.2K Buy
+10,084
New +$43.8K ﹤0.01% 3974
2021
Q2
Sell
-24,169
Closed -$943K 1790
2021
Q1
$943K Buy
24,169
+8,248
+52% +$371K 0.02% 694
2020
Q4
$642K Buy
+15,921
New +$731K 0.01% 856

Other funds holding GDRX

Cetera Investment Advisers's GDRX Position: Q2 2026 in Review

Cetera Investment Advisers held its GoodRx Holdings (GDRX) position steady in Q2 2026 at 10,217 shares worth $29.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4822.

Cetera Investment Advisers first reported a position in GDRX in Q4 2020 and has held it in 7 quarters since. The position peaked at $943K in Q1 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Cetera Investment Advisers held 10,217 shares of GoodRx Holdings worth $29.4K as of Q2 2026.
  • Cetera Investment Advisers left its GoodRx Holdings share count unchanged in Q2 2026.
  • GoodRx Holdings made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4822 holding.
  • Cetera Investment Advisers first reported a position in GoodRx Holdings in Q4 2020 and has held it in 7 quarters since.
  • Cetera Investment Advisers's GoodRx Holdings position peaked at $943K in Q1 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.